Horace Mann Educators (HMN)
(Delayed Data from NYSE)
$35.61 USD
+0.33 (0.94%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $35.60 -0.01 (-0.03%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$35.61 USD
+0.33 (0.94%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $35.60 -0.01 (-0.03%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth B Momentum B VGM
Zacks News
New Strong Sell Stocks for July 15th
by Zacks Equity Research
ACER, HMN, and STT have been added to the Zacks Rank #5 (Strong Sell) List on July 15, 2022.
Horace Mann (HMN) Estimates Q2 Cat Loss, Trims 2022 Guidance
by Zacks Equity Research
Horace Mann's (HMN) lowered guidance for 2022 reflects estimated cat loss and equity market declines.
Horace Mann (HMN) Okays Share Buyback Authorization of $50M
by Zacks Equity Research
Horace Mann (HMN) estimates generating about $50 million in excess capital annually in 2022 and beyond to support growth initiatives, buy back shares and hike dividends
Everest Re (RE) Rewards Shareholders With 6.4% Dividend Hike
by Zacks Equity Research
Everest Re's (RE) recent 6.4% hike in dividend reflects its intention to enhance shareholders' value, supported by its strong financial position.
RLI Bolsters Shareholder Value, Increases Dividend by 4%
by Zacks Equity Research
RLI's recent 4% hike in dividend reflects its intention to enhance shareholders' value supported by its strong financial position.
Horace Mann (HMN) Q1 Earnings Lag Estimates
by Zacks Equity Research
Horace Mann (HMN) delivered earnings and revenue surprises of -31.91% and 2.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) Eyes Q1 Earnings Beat on Cigna Healthcare Show
by Zacks Equity Research
Cigna's (CI) first-quarter 2022 results are likely to reflect improved pharmacy revenues in the Evernorth business.
Unum Group (UNM) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Unum Group's (UNM) Q1 earnings are likely to have benefited from persistency, growth in the dental and vision product line and growth in the in-force block.
Prudential (PRU) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Prudential's (PRU) Q1 results are likely to benefit from segmental strength and lower expense.
Is a Beat in the Cards for Assurant (AIZ) in Q1 Earnings?
by Zacks Equity Research
Assurant's (AIZ) first-quarter results are likely to reflect growth from strong U.S. sales in Global Automotive business, higher income from real estate-related investments, expansion in mobile within Connected Living and growth in Global Automotive.
Horace Mann (HMN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Horace Mann (HMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Horace Mann (HMN) Could Beat Earnings Estimates Again
by Zacks Equity Research
Horace Mann (HMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are You Looking for a High-Growth Dividend Stock? Horace Mann (HMN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes? Let's find out.
5 Insurers Set to Outshine Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help PRA, VOYA, HMN, AJG, and AFL outperform Q1 earnings estimates.
Why Should You Steer Clear of AMERISAFE (AMSF) Right Now?
by Zacks Equity Research
An escalating expense level and poor revenues make AMERISAFE (AMSF) an unattractive stock.
Zacks Industry Outlook Highlights MetLife, American International Group, The Hartford Financial Services Group, Old Republic International, and Horace Mann Educators
by Zacks Equity Research
MetLife, American International Group, The Hartford Financial Services Group, Old Republic International, and Horace Mann Educators are part of today's industry outlook article.
Why Horace Mann (HMN) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Horace Mann (HMN) have what it takes? Let's find out.
Why Should You Hold Aon's (AON) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on cost-cutting initiatives, strategic measures and a better bottom line, Aon (AON) holds potential to reap benefits for investors.
5 Multiline Insurers to Watch as Pandemic Impact Recedes
by Tanuka De
Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, HIG, ORI and HMN as the impact of the pandemic recedes.
Why is Hold Strategy Appropriate for CNO Financial (CNO)?
by Zacks Equity Research
CNO Financial (CNO) has enough potential to reap benefits for investors owing to strong investments in technology and cost-cutting measures.
Here's Why You Should Hold on to Trupanion (TRUP) Stock Now
by Zacks Equity Research
Trupanion (TRUP) is poised for growth in a total addressable market of $34.1 billion, given the change in the attitude of pet owners who are increasingly focusing on pets' health and well-being.
MetLife (MET) Unit Hits Milestone in Agricultural Mortgage Loans
by Zacks Equity Research
MetLife (MET) business unit MetLife Investment Management (MIM) creates a record by originating $6 billion in agricultural mortgage loans during 2021.
CME Group (CME) Unveils Micro-Sized Bitcoin and Ether Options
by Zacks Equity Research
CME Group (CME) introduces Micro Bitcoin and Micro Ether futures to add to the existing suite of cryptocurrency derivative offerings.
Should You Retain Prudential Financial (PRU) Stock Now?
by Zacks Equity Research
Prudential Financial (PRU) benefits from higher net investment spread and fee income, favorable underwriting results, and effective capital deployment.
Here's Why You Should Hold on to Argo Group (ARGO) Stock Now
by Zacks Equity Research
Argo Group's (ARGO) highly profitable businesses, exiting reinsurance operations and non-core lines of business, lowering property exposure substantially and reducing volatility bodes well for growth.